News & Updates
Filter by Specialty:
TAF useful in pregnant women with chronic hepatitis B infection
20 Dec 2021
Treatment with tenofovir alafenamide (TAF) for pregnant women with active chronic hepatitis B (CHB) infection, when administered throughout or initiated early in pregnancy, is effective and safe in both mothers and infants, according to a study.
TAF useful in pregnant women with chronic hepatitis B infection
20 Dec 2021IBD therapies do not increase risk of contracting COVID-19 after immunization
18 Dec 2021
byElaine Soliven
Using biologic/small molecules*, systemic steroids, or other agents** to treat patients with inflammatory bowel disease (IBD) does not increase the rate of SARS-CoV-2 infection at 3 and 6 months post-immunization, according to a study presented at AIBD 2021.